METiS TechBio ("METiS") today announced that two of its oncology pipeline candidates, MTS-105 and MTS-107, have been published in leading international peer-reviewed journals, Nature Communications ...

Genmab stock, Thursday's IBD Stock Of The Day, is just below an early entry in a cup case after announcing an $8 billion deal to buy Merus.

Objective response rate (ORR) of 75.0% including three very good partial responses (VGPR) in heavily pre-treated Waldenström ...

The Hong Kong and China Gas Company Limited (Towngas) and The Hong Kong University of Science and Technology (HKUST) today ...

The Galien Foundation, a global institution committed to recognizing collaborative scientific and medical innovations that advance patient care, celebrated the inaugural Prix Galien Bridges Awards on ...

Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free survival ...

When Wade Hayslip was 13 years old, a youth pastor pulled him aside and told him he needed to get out of his mother’s house. “Move in with your Wade Hayslip reflects on the pending execution of Chuck ...

The "Charm Offensive" in Pluribus' eighth episode revealed individuals are hiding inside the hive and Carol doesn't need ...

Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences ...

As you slay your way through Chapter 17 of Doom: The Dark Ages, you'll find a tougher demon that rewards you with an upgrade to your max ammo. This page acts as a comprehensive breakdown of the ...

Sales decreased 29.6% to 14,690 from the 20,859 in October 2024. Repercussions of the federal government shutdown continue to be a concern, despite Congress passing a short-term continuing resolution.